Space pictures pick up lots more penguins
LONDON (Reuters) - Scientists counting emperor penguins from space have found twice as many of the birds in Antarctica as expected. The discovery is reassuring for a species seen as...
Home > Reviews
All Stories
Fake drugs hard to spot amid 1,800 UK wholesalers
LONDON (Reuters) - Stamping out trade in counterfeit drugs like Roche's Avastin is an uphill fight for regulators, whose task is complicated by the presence of thousands of small wholesalers...
New batch of fake Avastin reached U.S. via Britain
LONDON (Reuters) - A new batch of counterfeit cancer drug Avastin discovered in the United States was bought in Turkey and shipped through Britain by UK-based middlemen, officials said on...
Fake drugs hard to spot amid 1,800 UK wholesalers
LONDON (Reuters) - Stamping out trade in counterfeit drugs like Roche's Avastin is an uphill fight for regulators, whose task is complicated by the presence of thousands of small wholesalers...
New batch of fake Avastin reached U.S. via Britain
LONDON (Reuters) - A new batch of counterfeit cancer drug Avastin discovered in the United States was bought in Turkey and shipped through Britain by UK-based middlemen, officials said on...
AstraZeneca hunting more deals like Amgen tie-up
LONDON (Reuters) - AstraZeneca is seeking more deals to fill its sparse drug pipeline like the one just signed with Amgen, but is not in the market for the kind...
AstraZeneca hunting more deals like Amgen tie-up
LONDON (Reuters) - AstraZeneca is seeking more deals to fill its sparse drug pipeline like the one just signed with Amgen, but is not in the market for the kind...
GSK’s new once-daily HIV drug matches Merck rival
LONDON (Reuters) - A new once-daily AIDS drug from GlaxoSmithKline and its partner Shionogi proved just as good as Merck & Co's twice-daily rival Isentress in a late-stage clinical trial,...
GSK’s new once-daily HIV drug matches Merck rival
LONDON (Reuters) - A new once-daily AIDS drug from GlaxoSmithKline and its partner Shionogi proved just as good as Merck & Co's twice-daily rival Isentress in a late-stage clinical trial,...
Insight: Chasing cheaper cancer drugs
LONDON (Reuters) - In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer...